We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGFV
3126
DELISTED
Big 5 Sporting Goods
BGFV
– –
-1,632
Closed -$5.75K
BIRD icon
3127
Smartbird Inc
BIRD
$31.3M
– –
-354
Closed -$4.91K
BIVI icon
3128
BioVie
BIVI
$24.5M
– –
-3
Closed -$145
BKKT icon
3129
Bakkt Inc
BKKT
$322M
– –
-171
Closed -$1.96K
BRBS icon
3130
Blue Ridge Bankshares
BRBS
$337M
– –
-1,360
Closed -$3.66K
BTAI icon
3131
BioXcel Therapeutics
BTAI
$32.7M
– –
-84
Closed -$3.81K
BW icon
3132
Babcock & Wilcox
BW
$1.4B
– –
-4,352
Closed -$4.92K
CARM
3133
DELISTED
Carisma Therapeutics
CARM
– –
-2,202
Closed -$5K
CATO icon
3134
Cato Corp
CATO
$66.3M
– –
-1,550
Closed -$8.94K
CCRD
3135
DELISTED
CoreCard
CCRD
– –
-598
Closed -$6.61K
CFFI icon
3136
C&F Financial
CFFI
$281M
– –
-271
Closed -$13.3K
CLPT icon
3137
ClearPoint Neuro
CLPT
$447M
– –
-1,893
Closed -$12.9K
CMA
3138
DELISTED
Comerica
CMA
– –
-1,465
Closed -$80.6K
CMBM
3139
DELISTED
Cambium Networks
CMBM
– –
-659
Closed -$2.84K
CMTL icon
3140
Comtech Telecommunications
CMTL
$51.8M
– –
-2,055
Closed -$7.05K
CNTY icon
3141
Century Casinos
CNTY
$34.3M
– –
-1,662
Closed -$5.25K
CTXR icon
3142
Citius Pharmaceuticals
CTXR
$18.9M
– –
-406
Closed -$9.11K
CUE icon
3143
Cue Biopharma
CUE
$115M
– –
-95
Closed -$5.39K
CVNA icon
3144
Carvana
CVNA
$77.4B
– –
-51,470
Closed -$905K
CXAI icon
3145
CXApp
CXAI
$17.8M
– –
-161
Closed -$394
DDS icon
3146
Dillards
DDS
$9.92B
– –
-360
Closed -$170K
DFLI icon
3147
Dragonfly Energy
DFLI
$18.8M
– –
-14
Closed -$679
DHX icon
3148
DHI Group
DHX
$172M
– –
-3,207
Closed -$8.18K
DLTH icon
3149
Duluth Holdings
DLTH
$150M
– –
-634
Closed -$3.11K
DOUG icon
3150
Douglas Elliman
DOUG
$190M
– –
-5,913
Closed -$9.34K
124 125
126
127 128

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.